Profile
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Former positions of Mark-Andre Freyberg
| Companies | Position | End |
|---|---|---|
| BIOXXMED AG | Chief Executive Officer | 2021-09-29 |
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology Develops biological medical products | President | 2007-09-02 |
Dermatools Biotech GmbH
Dermatools Biotech GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Founder | - |
Cytopharma GmbH | Founder | - |
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Training of Mark-Andre Freyberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bioXXmed AG
bioXXmed AG Pharmaceuticals: MajorHealth Technology Manufactures active ingredients | Health Technology |
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology Develops biological medical products | Health Technology |
Dermatools Biotech GmbH
Dermatools Biotech GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Commercial Services |
Cytopharma GmbH |
- Stock Market
- Insiders
- Mark-Andre Freyberg
















